Results 71 to 80 of about 5,163 (181)

Interaction of Ceftaroline with Clinically-Relevant β-Lactamases

open access: yes, 2015
Background: Ceftaroline fosamil is a cephalosporin approved for community-acquired pneumonia and acute bacterial skin and skin structure infections. Ceftaroline, the active metabolite of ceftaroline fosamil, has broad-spectrum in vitro activity against ...
DE LUCA, FILOMENA   +2 more
core   +1 more source

Ceftaroline fosamil in the treatment of methicillin-resistant Staphylococcus aureus [PDF]

open access: yes
Ceftaroline fosamil, a cephalosporin approved by the FDA for treating infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Staphylococcus aureus, particularly MRSA strains, poses a significant health risk due to antibiotic resistance.
D., Chandrakala   +3 more
core   +1 more source

กรณีศึกษา: ภาวะเกล็ดเลือดต่ำจากยา Ceftaroline ในผู้ป่วยวิกฤติ Case Report: Ceftaroline-Induced Thrombocytopenia in Critically Ill Patients [PDF]

open access: yes
บทคัดย่อ ยา ceftaroline เป็นยาปฏิชีวนะกลุ่ม cephalosporin ที่ออกฤทธิ์กว้าง รักษาการติดเชื้อแบคทีเรียทั้งแกรมบวก แกรมลบ แบคที่เรียที่ใช้ออกซิเจน และไม่ใช้ออกซิเจน รวมถึงแบคทีเรียดื้อยา บทความนี้กล่าวถึงกรณีศึกษาผู้ป่วยที่รักษาภาวะติดเชื้อ Methicillin ...
danwattana, ์nawarat
core  

Comparison of ceftriaxone versus ceftaroline in combination with ampicillin or penicillin against Enterococcus faecalis

open access: yesMicrobiology Spectrum
Enterococcus faecalis infective endocarditis treatment with ampicillin plus ceftriaxone has not changed the mortality rates by over 30%. We identified borderline-penicillin-resistant, ampicillin-susceptible E.
Olivia Gladys Funk   +3 more
doaj   +1 more source

The bacterial cell morphology of MRSA treated with ceftaroline.

open access: yes, 2016
TEM, A-D; SEM, (A´-D´). (A-A´) strain 06/1483 after exposure to 1/2 MIC of ceftaroline. (C-C´) strain 06/1483 without antibiotic. (B-B´) strain 05/3291 after exposure to 1/2 MIC of ceftaroline. (D-D´) strain 05/3291 without antibiotic.
José Ramos-Vivas (847494)   +6 more
core   +1 more source

The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials

open access: yes, 2019
Chih-Wei Chen,1,2 Shen-Peng Chang,3 Hui-Ting Huang,4 Hung-Jen Tang,5 Chih-Cheng Lai61Division of Neurosurgery, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan; 2Department of Occupational Safety and Health/Institute of Industrial Safety and
Chang SP   +4 more
core  

In vitro activity of ceftaroline against bacterial isolates causing skin and soft tissue and respiratory tract infections collected in Latin American countries, ATLAS program 2016–2020

open access: yesJournal of Global Antimicrobial Resistance
: Objectives: Ceftaroline, a broad-spectrum cephalosporin, has activity against Gram-positive and several Gram-negative bacteria (GNB). This study aimed to evaluate the antimicrobial activity of ceftaroline and comparators against isolates causing skin ...
Naglaa Mohamed   +5 more
doaj   +1 more source

Addition of ceftaroline fosamil or vancomycin to PMMA: An in vitro comparison of biomechanical properties and anti-MRSA efficacy

open access: yesJournal of Orthopaedic Surgery, 2019
Background: Ceftaroline is a cephalosporin that is effective against methicillin-resistant Staphylococcus aureus (MRSA) infections. The objective of this study was to determine the feasibility of using ceftaroline-loaded Polymethyl methacrylate (PMMA) as
Amber Haseeb   +3 more
doaj   +1 more source

AmpC induction by ceftaroline [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2010
Mushtaq, Shazad, Livermore, David M
openaire   +3 more sources

Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus [PDF]

open access: yes, 2020
The combination of vancomycin or daptomycin plus ceftaroline has showed synergistic results in vitro. This study aimed to investigate in vitro synergy of vancomycin or daptomycin plus ceftaroline for seven patients with daptomycin non-susceptible ...
Herc, Erica   +4 more
core  

Home - About - Disclaimer - Privacy